Rare diseases

Partner Content

Partner Content

Unpacking rare diseases in the first edition of Delta magazi...

Welcome to Delta – the new Fishawack Health magazine. We’ve chosen to focus our first edition of the magazine on a topic close to our hearts, rare diseases.

Partner Content

Real-world-evidence-rare-disease-pharmaphorum

Partner Content

Real-world evidence: breaking boundaries in rare disease

The COVID-19 pandemic has added a new layer of complexity to the drug development process.

News

bluebird bio to split into oncology and gene therapy special...

US biotech bluebird bio has announced plans to split into two this year, with a separate oncology business spinning off as the company prepares to bring its products to market.

Views & Analysis

2020 review - Pharma’s progress outside of COVID-19

2020 in review: Pharma’s progress outside of COVID-19

It has been a year dominated by the pandemic and many life sciences research projects were put on hold as big pharma turned its attention to vaccines and therapies.

R&D

Tay-Sachs and rare disease registries – the Health Heroes po...

Episode four of Kantar Health’s Health Heroes podcast tackles pharma’s rare disease challenges, the role of patient registries and hears a moving story about the rare genetic disorder Tay-S

Events